Sebastian Nikhil T, Glenn Chase, Hughes Ryan, Raval Raju, Chu Jacqueline, DiCostanzo Dominic, Bell Erica H, Grecula John, Arnett Andrea, Gondal Hasan, McGregor John, Elder James B, Lonser Russell, Chakravarti Arnab, Trifiletti Daniel, Brown Paul D, Chan Michael, Palmer Joshua D
Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA.
Department of Radiation Oncology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, USA.
Radiother Oncol. 2020 Jun;147:136-143. doi: 10.1016/j.radonc.2020.03.024. Epub 2020 Mar 30.
Gamma knife (GK) and linear accelerator (LINAC)-based stereotactic radiosurgery (SRS) both offer excellent local control in the management of multiple brain metastases. The efficacy and toxicity of LINAC and GK SRS have not been directly compared in the modern era. We studied outcomes in patients treated with LINAC SRS and GK at two separate institutions.
We identified patients treated with either LINAC or GK who were treated to ≥2 lesions and had available follow up. LINAC patients were treated using single-isocenter multitarget technique. We used Cox regression, Fine and Gray competing risks regression, and nearest neighbor propensity score matching to account for confounders and imbalance between cohorts. Kaplan-Meier curves were used to estimate overall survival and rates of radionecrosis.
We identified 391 patients who were treated in 537 courses to a total 2699 lesions (LINAC: 1014, GK: 1685). After propensity score matching, GK was associated with similar overall survival (HR = 0.86; 95% CI 0.59-1.24; p = 0.41) and higher rate of radionecrosis (HR = 3.83; 95% CI 1.66-8.84; p = 0.002) compared to LINAC. In a secondary propensity score matched analysis comparing radionecrosis in single-fraction LINAC and GK, GK remained associated with higher incidence of radionecrosis (HR = 4.42; 95% CI 1.28-15.29; p = 0.019).
In this multi-institutional study, we found similar overall survival with lower incidence of radionecrosis in patients treated with LINAC compared to GK SRS. These findings are hypothesis generating and should be validated in an independent cohort.
伽玛刀(GK)和基于直线加速器(LINAC)的立体定向放射外科治疗(SRS)在多脑转移瘤的治疗中均能实现出色的局部控制。在现代,LINAC和GK SRS的疗效和毒性尚未进行直接比较。我们研究了在两个不同机构接受LINAC SRS和GK治疗的患者的结局。
我们确定了接受LINAC或GK治疗且治疗≥2个病灶并可进行随访的患者。LINAC患者采用单等中心多靶点技术进行治疗。我们使用Cox回归、Fine和Gray竞争风险回归以及最近邻倾向评分匹配来处理混杂因素和队列之间的不平衡。采用Kaplan-Meier曲线估计总生存期和放射性坏死发生率。
我们确定了391例患者,共进行了537个疗程的治疗,涉及2699个病灶(LINAC:1014个,GK:1685个)。倾向评分匹配后,与LINAC相比,GK的总生存期相似(HR = 0.86;95%CI 0.59 - 1.24;p = 0.41),放射性坏死发生率更高(HR = 3.83;95%CI 1.66 - 8.84;p = 0.002)。在一项比较单次分割LINAC和GK放射性坏死的二次倾向评分匹配分析中,GK的放射性坏死发生率仍较高(HR = 4.42;95%CI 1.28 - 15.29;p = 0.019)。
在这项多机构研究中,我们发现与GK SRS相比,接受LINAC治疗的患者总生存期相似,但放射性坏死发生率较低。这些发现仅为假设,应在独立队列中进行验证。